Pa. Webster et al., ACETAMINOPHEN TOXICITY IN CHILDREN - DIAGNOSTIC CONFIRMATION USING A SPECIFIC ANTIGENIC BIOMARKER, Journal of clinical pharmacology, 36(5), 1996, pp. 397-402
Chronic acetaminophen (APAP) toxicity poses a difficult diagnostic cha
llenge to the clinician. Signs and symptoms are nonspecific and no cur
rently available laboratory study can confirm APAP as the causative ag
ent of hepatic injury. In this study an antigenic biomarker for APAP t
oxicity was used to confirm the diagnosis of APAP-induced hepatic fail
ure in two children with chronic APAP toxicity. APAP that has been met
abolized to N-acetyl-benzoquinone imine (NAPQI) reacts with cellular p
roteins to form 3-(cystein-S-yl)-APAP protein adducts (3-Cys-A). Serum
from both patients was submitted for quantitation of 3-Cys-A by a com
petitive inhibition enzyme-linked immunosorbent assay (ELISA). Concent
rations of 3-Cys-A in the two patients were 1.97 and 2.77 nmol/mg prot
ein, which are similar to concentrations found in adults with hepatic
injury secondary to an overdose of APAP. Individuals with no exposure
to APAP have no detectable 3-Cys-A in serum. It was concluded that 3-C
ys-A is a useful marker of APAP intoxication after long-term ingestion
of APAP when total dose and time course of ingestion are uncertain, a
nd may prove to be a useful clinical and investigative tool in the stu
dy of APAP intoxication.